1
|
Hoy D, Brooks P, Blyth F and Buchbinder R:
The Epidemiology of low back pain. Best Pract Res Clin Rheumatol.
24:769–781. 2010. View Article : Google Scholar
|
2
|
Takahashi K, Aoki Y and Ohtori S:
Resolving discogenic pain. Eur Spine J. 17(Suppl 4): S428–S431.
2008. View Article : Google Scholar
|
3
|
Hillman M, Wright A, Rajaratnam G, Tennant
A and Chamberlain MA: Prevalence of low back pain in the community:
Implications for service provision in Bradford UK. J Epidemiol
Community Health. 50:347–352. 1996. View Article : Google Scholar : PubMed/NCBI
|
4
|
Chen WH, Liu HY, Lo WC, Wu SC, Chi CH,
Chang HY, Hsiao SH, Wu CH, Chiu WT, Chen BJ and Deng WP:
Intervertebral disc regeneration in an ex vivo culture system using
mesenchymal stem cells and platelet-rich plasma. Biomaterials.
30:5523–5533. 2009. View Article : Google Scholar : PubMed/NCBI
|
5
|
Pockert AJ, Richardson SM, Le Maitre CL,
Lyon M, Deakin JA, Buttle DJ, Freemont AJ and Hoyland JA: Modified
expression of the ADAMTS enzymes and tissue inhibitor of
metallo-proteinases 3 during human intervertebral disc
degeneration. Arthritis Rheum. 60:482–491. 2009. View Article : Google Scholar : PubMed/NCBI
|
6
|
Ding F, Shao ZW, Yang SH, Wu Q, Gao F and
Xiong LM: Role of mitochondrial pathway in compression-induced
apoptosis of nucleus pulposus cells. Apoptosis. 17:579–590. 2012.
View Article : Google Scholar : PubMed/NCBI
|
7
|
Vonk LA, Kroeze RJ, Doulabi BZ,
Hoogendoorn RJ, Huang C, Helder MN, Everts V and Bank RA: Caprine
articular, meniscus and intervertebral disc cartilage: An integral
analysis of collagen network and chondrocytes. Matrix Biol.
29:209–218. 2010. View Article : Google Scholar
|
8
|
Zhao CQ, Jiang LS and Dai LY: Programmed
cell death in inter-vertebral disc degeneration. Apoptosis.
11:2079–2088. 2006. View Article : Google Scholar : PubMed/NCBI
|
9
|
Zhao CQ, Liu D, Li H, Jiang LS and Dai LY:
Interleukin-1beta enhances the effect of serum deprivation on rat
annular cell apoptosis. Apoptosis. 12:2155–2161. 2007. View Article : Google Scholar : PubMed/NCBI
|
10
|
Gruber HE and Hanley EN Jr: Analysis of
aging and degeneration of the human intervertebral disc. Comparison
of surgical specimens with normal controls. Spine (Phila Pa 1976).
23:751–757. 1998. View Article : Google Scholar
|
11
|
Ha KY, Kim BG, Kim KW, Oh IS and Seo JY:
Apoptosis in the sequestrated nucleus pulposus compared to the
remaining nucleus pulposus in the same patient. Spine (Phila Pa
1976). 36:683–689. 2011. View Article : Google Scholar
|
12
|
Kaneyama S, Nishida K, Takada T, Suzuki T,
Shimomura T, Maeno K, Kurosaka M and Doita M: Fas ligand expression
on human nucleus pulposus cells decreases with disc degeneration
processes. J Orthop Sci. 13:130–135. 2008. View Article : Google Scholar : PubMed/NCBI
|
13
|
Kuo YJ, Wu LC, Sun JS, Chen MH, Sun MG and
Tsuang YH: Mechanical stress-induced apoptosis of nucleus pulposus
cells: An in vitro and in vivo rat model. J Orthop Sci. 19:313–322.
2014. View Article : Google Scholar
|
14
|
Park JB, Lee JK, Park EY and Riew KD:
Fas/FasL interaction of nucleus pulposus and cancer cells with the
activation of caspases. Int Orthop. 32:835–840. 2008. View Article : Google Scholar
|
15
|
Li F and Brattain MG: Role of the Survivin
gene in pathophysiology. Am J Pathol. 169:1–11. 2006. View Article : Google Scholar : PubMed/NCBI
|
16
|
Wheatley SP and McNeish IA: Survivin: A
protein with dual roles in mitosis and apoptosis. Int Rev Cytol.
247:35–88. 2005. View Article : Google Scholar : PubMed/NCBI
|
17
|
Ambrosini G, Adida C and Altieri DC: A
novel anti-apoptosis gene, survivin, expressed in cancer and
lymphoma. Nat Med. 3:917–921. 1997. View Article : Google Scholar : PubMed/NCBI
|
18
|
Li F and Ling X: Survivin study: An update
of 'what is the next wave'? J Cell Physiol. 208:476–486. 2006.
View Article : Google Scholar : PubMed/NCBI
|
19
|
Jiang Y, de Bruin A, Caldas H, Fangusaro
J, Hayes J, Conway EM, Robinson ML and Altura RA: Essential role
for survivin in early brain development. J Neurosci. 25:6962–6970.
2005. View Article : Google Scholar : PubMed/NCBI
|
20
|
Zhao J, Tenev T, Martins LM, Downward J
and Lemoine NR: The ubiquitin-proteasome pathway regulates survivin
degradation in a cell cycle-dependent manner. J Cell Sci. 113(Pt
23): 4363–4371. 2000.PubMed/NCBI
|
21
|
Tanaka K, Iwamoto S, Gon G, Nohara T,
Iwamoto M and Tanigawa N: Expression of survivin and its
relationship to loss of apoptosis in breast carcinomas. Clin Cancer
Res. 6:127–134. 2000.PubMed/NCBI
|
22
|
Lechler P, Balakrishnan S, Schaumburger J,
Grässel S, Baier C, Grifka J, Straub RH and Renkawitz T: The
oncofetal gene survivin is re-expressed in osteoarthritis and is
required for chondrocyte proliferation in vitro. BMC Musculoskelet
Disord. 12:1502011. View Article : Google Scholar : PubMed/NCBI
|
23
|
Baran M, Möllers LN, Andersson S, Jonsson
IM, Ekwall AK, Bjersing J, Tarkowski A and Bokarewa M: Survivin is
an essential mediator of arthritis interacting with urokinase
signalling. J Cell Mol Med. 13:3797–3808. 2009. View Article : Google Scholar : PubMed/NCBI
|
24
|
Bokarewa M, Tarkowski A and Magnusson M:
Pathological survivin expression links viral infections with
pathogenesis of erosive rheumatoid arthritis. Scand J Immunol.
66:192–198. 2007. View Article : Google Scholar : PubMed/NCBI
|
25
|
Pfirrmann CW, Metzdorf A, Zanetti M,
Hodler J and Boos N: Magnetic resonance classification of lumbar
intervertebral disc degeneration. Spine (Phila Pa 1976).
26:1873–1878. 2001. View Article : Google Scholar
|
26
|
Warnecke C, Zaborowska Z, Kurreck J,
Erdmann VA, Frei U, Wiesener M and Eckardt KU: Differentiating the
functional role of hypoxia-inducible factor (HIF)-1alpha and
HIF-2alpha (EPAS-1) by the use of RNA interference: Erythropoietin
is a HIF-2alpha target gene in Hep3B and Kelly cells. FASEB J.
18:1462–1464. 2004.PubMed/NCBI
|
27
|
Buckwalter JA: Aging and degeneration of
the human intervertebral disc. Spine (Phila Pa 1976). 20:1307–1314.
1995.
|
28
|
Buckwalter JA, Woo SL, Goldberg VM, Hadley
EC, Booth F, Oegema TR and Eyre DR: Soft-tissue aging and
musculoskeletal function. J Bone Joint Surg Am. 75:1533–1548.
1993.PubMed/NCBI
|
29
|
Ghadimi MP, Young ED, Belousov R, Zhang Y,
Lopez G, Lusby K, Kivlin C, Demicco EG, Creighton CJ, Lazar AJ, et
al: Survivin is a viable target for the treatment of malignant
peripheral nerve sheath tumors. Clin Cancer Res. 18:2545–2557.
2012. View Article : Google Scholar : PubMed/NCBI
|
30
|
Romagnoli M, Séveno C, Bataille R and
Barillé-Nion S: Survivin in cancerology: Molecular aspects and
therapeutic applications. Med Sci (Paris). 24:821–827. 2008.In
French. View Article : Google Scholar
|
31
|
Yang KS, Yue B and Ma XX: The expression
of survivin and its significance in fetal intervertebral disc.
Qingdao Daxue Yixueyuan Xuebao. 49:205–206. 2013.
|
32
|
Yang KS: The expression of survivin and
its significance ininter-vertebral disc. Dissertation. Qingdao
University; 2013
|
33
|
Chen J, Wu W, Tahir SK, Kroeger PE,
Rosenberg SH, Cowsert LM, Bennett F, Krajewski S, Krajewska M,
Welsh K, et al: Down-regulation of survivin by antisense
oligonucleotides increases apoptosis, inhibits cytokinesis and
anchorage-independent growth. Neoplasia. 2:235–241. 2000.
View Article : Google Scholar : PubMed/NCBI
|
34
|
Reed JC and Bischoff JR: BIRinging
chromosomes through cell division-and survivin' the experience.
Cell. 102:545–548. 2000. View Article : Google Scholar : PubMed/NCBI
|
35
|
Skoufias DA, Mollinari C, Lacroix FB and
Margolis RL: Human survivin is a kinetochore-associated passenger
protein. J Cell Biol. 151:1575–1582. 2000. View Article : Google Scholar
|
36
|
Anderson DG and Tannoury C: Molecular
pathogenic factors in symptomatic disc degeneration. Spine J. 5(6
Suppl): S260–S266. 2005. View Article : Google Scholar
|
37
|
Kim KW, Lim TH, Kim JG, Jeong ST, Masuda K
and An HS: The origin of chondrocytes in the nucleus pulposus and
histologic findings associated with the transition of a notochordal
nucleus pulposus to a fibrocartilaginous nucleus pulposus in intact
rabbit intervertebral discs. Spine (Phila Pa 1976). 28:982–990.
2003. View Article : Google Scholar
|